| 1 | An overview of Cdk1-controlled targets and processes (10.1186/1747-1028-5-11) | Abstract References ORCID License | 256.82 | 369 |
| 2 | Anti cancer effects of curcumin: cycle of life and death (10.1186/1747-1028-3-14) | Abstract References ORCID License | 246.54 | 291 |
| 3 | Cullin-RING ubiquitin ligases: global regulation and activat… (10.1186/1747-1028-3-7) | Abstract References ORCID License | 240.14 | 251 |
| 4 | Cdc25 and Wee1: analogous opposites? (10.1186/1747-1028-2-12) | Abstract References ORCID License | 214.92 | 140 |
| 5 | Distinct and redundant functions of cyclin E1 and cyclin E2… (10.1186/1747-1028-5-2) | Abstract References ORCID License | 210.04 | 125 |
| 6 | Septins: molecular partitioning and the generation of cellul… (10.1186/1747-1028-4-18) | Abstract References ORCID License | 209.34 | 123 |
| 7 | JAB1/CSN5: a new player in cell cycle control and cancer (10.1186/1747-1028-5-26) | Abstract References ORCID License | 206.45 | 115 |
| 8 | — (10.1186/1747-1028-1-13) | Abstract References ORCID License | 206.07 | 114 |
| 9 | Emerging roles of the SUMO pathway in mitosis (10.1186/1747-1028-3-5) | Abstract References ORCID License | 202.94 | 106 |
| 10 | — (10.1186/1747-1028-2-7) | Abstract References ORCID License | 200.86 | 101 |
| 11 | Mechanisms of mono- and poly-ubiquitination: Ubiquitination… (10.1186/1747-1028-5-19) | Abstract References ORCID License | 200.86 | 101 |
| 12 | Cyclin K goes with Cdk12 and Cdk13 (10.1186/1747-1028-7-12) | Abstract References ORCID License | 200.86 | 101 |
| 13 | — (10.1186/1747-1028-2-5) | Abstract References ORCID License | 200.43 | 100 |
| 14 | — (10.1186/1747-1028-2-4) | Abstract References ORCID License | 199.12 | 97 |
| 15 | — (10.1186/1747-1028-1-22) | Abstract References ORCID License | 197.77 | 94 |
| 16 | The function of APC/CCdh1 in cell cycle and beyond (10.1186/1747-1028-4-2) | Abstract References ORCID License | 197.77 | 94 |
| 17 | Regulation of DNA replication by the S-phase DNA damage chec… (10.1186/1747-1028-4-13) | Abstract References ORCID License | 186.33 | 72 |
| 18 | Polo-like kinase 4: the odd one out of the family (10.1186/1747-1028-5-25) | Abstract References ORCID License | 186.33 | 72 |
| 19 | — (10.1186/1747-1028-1-19) | Abstract References ORCID License | 183.25 | 67 |
| 20 | — (10.1186/1747-1028-1-30) | Abstract References ORCID License | 182.61 | 66 |
| 21 | Regulation of the retinoblastoma proteins by the human herpe… (10.1186/1747-1028-4-1) | Abstract References ORCID License | 182.61 | 66 |
| 22 | Structure-function analysis of the retinoblastoma tumor supp… (10.1186/1747-1028-2-26) | Abstract References ORCID License | 179.93 | 62 |
| 23 | A dual role of Cdk2 in DNA damage response (10.1186/1747-1028-4-9) | Abstract References ORCID License | 179.93 | 62 |
| 24 | The retinoblastoma family of proteins and their regulatory f… (10.1186/1747-1028-7-10) | Abstract ORCID License | 179.32 | 245 |
| 25 | Cdt1 degradation to prevent DNA re-replication: conserved an… (10.1186/1747-1028-2-18) | Abstract References ORCID License | 177.09 | 58 |
| 26 | P-TEFb- the final frontier (10.1186/1747-1028-4-19) | Abstract References ORCID License | 176.34 | 57 |
| 27 | Proteomics, pathway array and signaling network-based medici… (10.1186/1747-1028-4-20) | Abstract References ORCID License | 175.59 | 56 |
| 28 | — (10.1186/1747-1028-1-15) | Abstract References ORCID License | 174.04 | 54 |
| 29 | p107 in the public eye: an Rb understudy and more (10.1186/1747-1028-5-9) | Abstract References ORCID License | 167.21 | 46 |
| 30 | — (10.1186/1747-1028-1-16) | Abstract References ORCID License | 164.35 | 43 |
| 31 | — (10.1186/1747-1028-1-29) | Abstract References ORCID License | 162.32 | 41 |
| 32 | Insights from mouse models into human retinoblastoma (10.1186/1747-1028-3-9) | Abstract References ORCID License | 161.28 | 40 |
| 33 | The balance of Polo-like kinase 1 in tumorigenesis (10.1186/1747-1028-4-4) | Abstract References ORCID License | 159.11 | 38 |
| 34 | To divide or not to divide: revisiting liver regeneration (10.1186/1747-1028-8-8) | Abstract ORCID License | 158.80 | 130 |
| 35 | Curcumin and tumor immune-editing: resurrecting the immune s… (10.1186/s13008-015-0012-z) | Abstract ORCID License | 158.80 | 130 |
| 36 | New insights into the functions and regulation of the transc… (10.1186/1747-1028-4-7) | Abstract References ORCID License | 157.98 | 37 |
| 37 | Self-organization of intracellular gradients during mitosis (10.1186/1747-1028-5-5) | Abstract References ORCID License | 154.41 | 34 |
| 38 | Preventing DNA over-replication: a Cdk perspective (10.1186/1747-1028-3-3) | Abstract References ORCID License | 153.15 | 33 |
| 39 | — (10.1186/1747-1028-1-10) | Abstract References ORCID License | 150.51 | 31 |
| 40 | — (10.1186/1747-1028-2-1) | Abstract References ORCID License | 150.51 | 31 |
| 41 | Self-regulated mechanism of Plk1 localization to kinetochore… (10.1186/1747-1028-3-4) | Abstract References ORCID License | 150.51 | 31 |
| 42 | The role of cullin 5-containing ubiquitin ligases (10.1186/s13008-016-0016-3) | Abstract ORCID License | 149.67 | 98 |
| 43 | Real-time in vivo imaging of p16Ink4a gene expression: a new… (10.1186/1747-1028-5-1) | Abstract References ORCID License | 149.14 | 30 |
| 44 | RBX1/ROC1-SCF E3 ubiquitin ligase is required for mouse embr… (10.1186/1747-1028-4-16) | Abstract References ORCID License | 147.71 | 29 |
| 45 | Regulated degradation of the APC coactivator Cdc20 (10.1186/1747-1028-5-23) | Abstract References ORCID License | 147.71 | 29 |
| 46 | Therapeutic targeting of cancer cell cycle using proteasome… (10.1186/1747-1028-7-26) | Abstract ORCID License | 147.64 | 92 |
| 47 | — (10.1186/1747-1028-1-26) | Abstract References ORCID License | 146.24 | 28 |
| 48 | MIF coordinates the cell cycle with DNA damage checkpoints.… (10.1186/1747-1028-2-22) | Abstract References ORCID License | 146.24 | 28 |
| 49 | The anti-apoptotic factor Che-1/AATF links transcriptional r… (10.1186/1747-1028-2-21) | Abstract References ORCID License | 144.72 | 27 |
| 50 | Chk1 suppressed cell death (10.1186/1747-1028-5-21) | Abstract References ORCID License | 144.72 | 27 |